IMMUNITYBIO INC (IBRX:NASDAQ)
$7.81 -0.41 (-4.9878%)
Analysed IMMUNITYBIO INC (IBRX:NASDAQ) News Sources
SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna’s Rally As MRNA Lands A Nasdaq-100 Spot
02-10-2026
stocktwits.com
IBRX Stock Logs Best Week In Over 7 Months: Retail Eyes Anktiva Boost From Trump’s Cancer Panel Pick
05-10-2026
stocktwits.com
ImmunityBio (IBRX) Could Be 33% Undervalued Following Its Ottawa Symposium Update
08-10-2026
yahoo.com
SLS, IBRX Rise Premarket: Funds Raise Their Bets As J&J Stays ‘On The Lookout’ For Deals
14-10-2026
stocktwits.com
IBRX Stock Rallies After FDA Clears Broader Anktiva Use In Bladder Cancer Months Ahead Of Deadline
14-10-2026
stocktwits.com
FDA Expands ANKTIVA® Approval for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer to Cover Both Papillary and CIS Disease
14-10-2026
yahoo.com
IBRX Stock Eyes Weekly Slump Despite Anktiva FDA Win — Retail Stays Cautious Ahead Of Founder’s Trial Talk
15-10-2026
stocktwits.com
ImmunityBio Reports Phase 3 Data Showing 84% Cystectomy Avoidance at Three Years and Complete Responses Beyond 53 Months with ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC With CIS, With or Without Papillary Tumors
16-10-2026
yahoo.com
ImmunityBio Announces Database Lock for Registrational Trial of Locally Delivered, Chemotherapy-Free ANKTIVA® Plus BCG in BCG-Naïve Non-Muscle Invasive Bladder Cancer
21-10-2026
yahoo.com
ImmunityBio Locks Anktiva Trial Database, Eyes November Results As FDA Filing Nears
21-10-2026
stocktwits.com
What is the current price of IMMUNITYBIO INC (IBRX:NASDAQ)?
The current price of IMMUNITYBIO INC (IBRX:NASDAQ) is $7.81.
IMMUNITYBIO INC (IBRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMUNITYBIO INC (IBRX:NASDAQ) since the previous trading day is $-0.41.
IMMUNITYBIO INC (IBRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMUNITYBIO INC (IBRX:NASDAQ) since the previous trading day is -4.9878%.
What is the most recent average sentiment score for IMMUNITYBIO INC (IBRX:NASDAQ)?
The most recent average sentiment score for IMMUNITYBIO INC (IBRX:NASDAQ) is 66 out of 100.
What is the most recent average sentiment for IMMUNITYBIO INC (IBRX:NASDAQ)?
The most recent sentiment for IMMUNITYBIO INC (IBRX:NASDAQ) is .
SEC-8K** Filing Available For IMMUNITYBIO INC (IBRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.